Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
暂无分享,去创建一个
Herbert Stepp | Martin Kriegmair | Dirk Zaak | Alexander Karl | Arndt Hartmann | Stefan Tritschler | R. Knuechel | H. Stepp | C. Stief | A. Hartmann | S. Tritschler | M. Kriegmair | D. Zaak | A. Hofstetter | Christian Stief | Ruth Knuechel | Alfons Hofstetter | A. Karl | E. Hungerhuber | Edwin Hungerhuber
[1] Herbert Stepp,et al. Role of 5‐aminolevulinic acid in the detection of urothelial premalignant lesions , 2002, Cancer.
[2] Gerhard Jakse,et al. A second-look TUR in T1 transitional cell carcinoma: why? , 2004, European urology.
[3] A. Althausen,et al. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. , 1976, The Journal of urology.
[4] R. Knuechel,et al. Clinical Results of the Transurethral Resection and Evaluation of Superficial Bladder Carcinomas by Means of Fluorescence Diagnosis after Intravesical Instillation of 5-Aminolevulinic Acid , 1999 .
[5] G. Steineck,et al. Prevention and Treatment of Urothelial Premalignant and Malignant Lesions , 2000, Scandinavian journal of urology and nephrology. Supplementum.
[6] J. Cheville,et al. Flat intraepithelial lesions of the urinary bladder , 2000, Cancer.
[7] L. Guillou,et al. Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light‐induced fluorescence of protoporphyrin IX following topical application of 5‐aminolevulinic acid: Preliminary results , 1997, Lasers in surgery and medicine.
[8] K. Schomacker,et al. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5‐aminolaevulinic acid , 1999, BJU international.
[9] L. Kiemeney,et al. Random bladder biopsies and the risk of recurrent superficial bladder cancer: a prospective study in 1026 patients , 1992, World Journal of Urology.
[10] R. Knuechel,et al. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses , 2003, The Journal of pathology.
[11] G. Steineck,et al. Epidemiology and Etiology of Premalignant and Malignant Urothelial Changes , 2000, Scandinavian journal of urology and nephrology. Supplementum.
[12] Thomas Filbeck,et al. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. , 2002, The Journal of urology.
[13] C. De Nunzio,et al. Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity. , 2001, Urology.
[14] M. Soloway,et al. Serial multiple-site biopsies in patients with bladder cancer. , 1978, The Journal of urology.
[15] R. Knuechel,et al. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. , 2002, Cancer research.
[16] H Stepp,et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.
[17] S. Wilczynski,et al. The accuracy of urinary cytology in daily practice , 1999, Cancer.
[18] J. Rassweiler,et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. , 2002, The Journal of urology.
[19] D. Zaak,et al. The Current Diagnosis of Superficial Bladder Cancer Must Be Reconsidered , 2002, Urologia Internationalis.
[20] F M Debruyne,et al. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. , 1994, European journal of cancer.
[21] W Roessler,et al. 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors. , 1999, Urology.
[22] R. Sylvester,et al. Significance of Bladder Biopsies in Ta,T1 Bladder Tumors: A Report from the EORTC Genito-Urinary Tract Cancer Cooperative Group , 1999, European Urology.
[23] P Schneede,et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. , 2001, Urology.
[24] J. Witjes. Bladder carcinoma in situ in 2003: state of the art. , 2004, European urology.
[25] R. Knuechel,et al. [Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study]. , 2003, Der Urologe. Ausg. A.
[26] A Hofstetter,et al. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. , 1999, The American journal of pathology.
[27] J. Cheville,et al. Natural history of urothelial dysplasia of the bladder. , 1999, The American journal of surgical pathology.
[28] H. Huland,et al. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. , 1991, The Journal of urology.
[29] C. Busch,et al. Recurrence and progression in low grade papillary urothelial tumors. , 1999, The Journal of urology.